For research use only
| Cat No. | ABC-X0325C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocytes |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human ETV6_CRAF (Y360H) BAF3 Cell Line supports analysis of CRAF fusion-induced MAPK signaling activation and therapeutic response in leukemia models.
Human ETV6_CRAF (Y360H) BAF3 Overexpression Cell Line is a genetically modified Ba/F3 model stably expressing the human ETV6_CRAF fusion gene with a Y360H point mutation. Lentiviral vectors are used for integration, and clonal lines are maintained at low passage numbers (<P20) and validated via qRT-PCR. Target The ETV6_CRAF fusion results in constitutive activation of the MAPK signaling pathway, with the Y360H mutation further enhancing kinase activity. This oncogenic alteration has been implicated in hematologic malignancies such as leukemia. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers' research needs.
| Species | Human |
| Cat.No | ABC-X0325C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocytes |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
This cell line is a valuable platform for elucidating ETV6_CRAF-mediated oncogenesis and for screening RAF pathway inhibitors targeting drug-resistant leukemia phenotypes.